Thirty Madison funding, news & analysis

Unlock Full Access Sign In

Home > Companies > Thirty Madison

Thirty Madison

Telehealth service for chronic conditions like hair loss, migraines, reflux, and allergies

#telehealth

Funding

$285.46M

2022

Details

Headquarters

New York, United States

Website

Milestones

FOUNDING YEAR

2017

Listed In

#telehealth

Research and interviews about Thirty Madison.

Loading reports…

The latest coverage and announcements from Thirty Madison.

Company documents and regulatory filings for Thirty Madison.

Name	Type	Filed At	Actions
No filings found.

Date	Event	Valuation	Amount	Price	Status
Sep 2025	To be acquired by Remedy Meds, LLC Sources Remedy Meds Thirty Madison Acquire axios.com "Telehealth startup Remedy Meds is acquiring rival Thirty Madison, in a deal valued at "north of $500 million," Remedy Meds CEO Haris Memon tells Axios."	—	—	—	Announced
Unlock Thirty Madison data Sign up for data access
Mar 2022	Series D	—	—	—	Closed
Jun 2021	Series C	—	—	—	Closed
Aug 2020	Series B	—	—	—	Closed
Oct 2018	Series A	—	—	—	Closed
Nov 2017	Seed	—	—	—	Closed

Details

Headquarters

New York, United States

Website

Milestones

FOUNDING YEAR

2017

Listed In

#telehealth